Ojeda-Fernández Luisa, Baviera Marta, Foresta Andreana, Tettamanti Mauro, Zambon Antonella, Macaluso Giulia, Schena Simone, Leoni Olivia, Fortino Ida, Roncaglioni Maria Carla, Parati Gianfranco
Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Laboratory of Geriatric Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Front Cardiovasc Med. 2023 Sep 12;10:1244002. doi: 10.3389/fcvm.2023.1244002. eCollection 2023.
COVID-19 has been associated with a higher risk of post-acute complications. Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 survivors of the first and second/third pandemic waves in Lombardy, in both hospitalized and non-hospitalized COVID-19 patients.
We included adults aged ≥40 years infected during the first and second/third waves of COVID-19 pandemic. The follow-up initiated 30 days after COVID-19 diagnosis and continued up to 9 months. Hazard ratios (HRs) and 95% confidence intervals (CIs) of the post-acute cardiovascular outcomes were calculated against an inverse probability treatment weighted control group. Subgroup analysis were performed by age classes, sex, previous cardiovascular disease and stratified by COVID-19 hospitalization status to explore the impact of COVID-19 severity on outcomes. Compared to the control group, COVID-19 patients had an increased risk of hospitalization for any cardiovascular complications (HR 1st wave 1.53 95% CI: 1.38-1.69; HR 2nd/3rd wave 1.25 95% CI: 1.19-1.31) and for individual cardiovascular outcomes, although HRs were higher in COVID-19 group from the 1st pandemic wave. The results were confirmed in the subgroup analyses. Of note, the risk for any cardiovascular disease was also evident even among individuals who were not hospitalized during the acute phase of the infection.
Our results provide evidence that COVID-19 is a risk factor for post-acute cardiovascular complications among different pandemic waves regardless of COVID-19 severity, age, sex and a history of cardiovascular diseases. Care strategies of people with COVID-19 should include cardiac monitoring.
2019冠状病毒病(COVID-19)与急性后并发症风险较高有关。我们的目的是分析和比较伦巴第大区第一波和第二/三波大流行期间COVID-19幸存者(包括住院和非住院的COVID-19患者)的急性后心血管并发症。
我们纳入了年龄≥40岁、在COVID-19大流行第一波和第二/三波期间感染的成年人。随访在COVID-19诊断后30天开始,持续至9个月。针对逆概率治疗加权对照组计算急性后心血管结局的风险比(HR)和95%置信区间(CI)。按年龄组、性别、既往心血管疾病进行亚组分析,并按COVID-19住院状态分层,以探讨COVID-19严重程度对结局的影响。与对照组相比,COVID-19患者发生任何心血管并发症住院的风险增加(第一波HR 1.53,95%CI:1.38 - 1.69;第二/三波HR 1.25,95%CI:1.19 - 1.31),以及发生个体心血管结局的风险增加,尽管第一波大流行期间COVID-19组的HR更高。亚组分析证实了这些结果。值得注意的是,即使在感染急性期未住院的个体中,发生任何心血管疾病的风险也很明显。
我们的结果表明,无论COVID-19的严重程度、年龄、性别和心血管疾病史如何,COVID-19都是不同大流行波期间急性后心血管并发症的危险因素。COVID-19患者的护理策略应包括心脏监测。